Hong Kong: Kangji Medical plans Hong Kong IPO

Kangji Medical, the largest domestic minimally invasive surgical instruments and accessories platform in China, is planning an up to US$500m initial public offering on the Hong Kong Stock Exchange. Its product portfolio is focused on OBGYN, general surgery, urology and thoracic surgery with manufacturing out of facilities in Tonglu, Zhejiang Province. Profits last year hit…

You must be a HMI Subscriber to view this content.

Subscribe Now »